a combination chemotherapy ( macc ) consisting of methotrexate , doxorubicin hydrochloride ( adriamycin ) , cyclophosphamide , and lomustine ( ccnu ) was given to 41 patients with stage iii bronchogenic carcinoma , 34 of whom had disseminated disease .
C0546861
doxorubicin
C0085752
adriamycin